Introduced below is the history of DAIICHI SANKYO, including the development of
Sankyo and Daiichi Pharmaceutical since their founding.

History of Sankyo Co., Ltd.		Year	History of Daiichi Pharmaceutical Co., Ltd.
	・Founding of Sankyo Shoten (financed jointly by Matasaku Shiobara, Shotaro Nishimura, Genjiro Fukui) ・Launched digestive enzyme Taka-Diastase® (In 1894 [Meiji 27] Dr.Jokichi Takamine discovered the digestive enzyme Taka-Diastase from a fungus)	1899 Meiji 32		-
	・Launched Adrenalin®, an adrenal cortex hormone agent	1902 Meiji 35		-
	・Established Hakozaki plant	1905 Meiji 38		-
	・Established Shinagawa plant	1908 Meiji 41		-
	・Dr. Umetaro Suzuki (appointed as a Sankyo scientific adviser in 1920 [Taisho 9]) made the world's first discovery of vitamin B1(Orizanin®）from rice bran, establishing the basis for the theory of vitamins	1910 Meiji 43		-
	・Established Sankyo Co., Ltd. ・Dr. Jokichi Takamine becomes first president	1913 Taisho 2		-
	・Established Osaka Factory	1915 Taisho 4		・Dr. Katsuzaemon Keimatsu and others established Arsemin Shokai (October 1)
	-			・Establishment of Yanagishima plant ・Launched Arsemin®, an anti-syphilitic agent
	-	1916 Taisho 5		・Launched Neo Neo Arsemin®, an anti-syphilitic agent
	-	1918 Taisho 7		・Established Daiichi Pharmaceutical Co., Ltd ・Seinosuke Shibata appointed as first president
	・Started manufacture of Japan's first synthetic agricultural chemical, the fumigant insecticide KOKUZOL®	1921 Taisho 10		・Launched Bosmin®, a vasoconstriction/hemostasis and asthma medicine (a long-run drug)
	-	1929 Showa 4		・Completion of former Head Office
	・Started manufacture of yeast for bread	1932 Showa 7		-
	-	1933 Showa 8		・Operations started at Takatsuki plant
	-	1937 Showa 12		・Launched Therapol®, the first domestically produced Sulfa
	-	1938 Showa 13		・Established Funabori plant (1938-1982)
	-	1948 Showa 23		・Launched Teradiazin®, the first domestically produced sulfadiazine medicine
	・Listed on Tokyo Stock Exchang	1949 Showa 24		・Listed on Tokyo Stock Exchange
	・Launched LULU® ,cold medicine ・Manufactured the first domestically produced antibiotic preparation Chloromycetin®	1951 Showa 26		-
	-	1952 Showa 27		・Launched Iscotin®, a medicine for phthisis
	-	1953 Showa 28		・Launched high-strength Vita Baby Vitamins® (over-the-counter medicine)
	-	1956 Showa 31		・Launched Atraxin®, the first domestically produced antipsychotic medicine
	・Launched Sankyo Ichoyaku	1957 Showa 32		-
	・Established New York Subsidiary (New York USA)	1961 Showa 36		・Established new Central Research Laboratory
	・Research division spun off from head office and set up as an independent research laboratory	1962 Showa 37		・Launched world's first anti-plasmin medicine Ipsilon® ・Launched Pancy®, an over-the-counter vitamin preparation
	・Established Basel subsidiary （Basel, Switzerland） ・Completed Head Office Forwarding Center	1963 Showa 38		・Launched Trancopal® an over-the-counter tranquilizer
	・Research Laboratory becomes Central Research Laboratory, Production Research Laboratory and Agricultural Research Laboratory	1965 Showa 40		・Completion of Head Office
	・Launched Vitamedin®, a vitamin, B1, B6 and B12 compound			・Launched Transamin®, an anti-plasmin medicine
	・Established Hiratsuka plant	1966 Showa 41		・Launched Patecs®, the first shape-forming poultic (OTC medicine)
	・Launched first domestically produced minor tranquilizer Serenal®	1970 Showa 45		-
	・ Launched agricultural pesticide Tachigaren®	1971 Showa 46		-
	・Launched Sanol®, a high polymer stabilizing compound	1972 Showa 47		-
	-	1973 Showa 48		・Launched Karoyan®, a hair-loss prevention and vitiligo agent
	-	1975 Showa 50		・Established Japan Research Foundation for Clinical Pharmacology, commemorating the 60th anniversary of the company's founding
	・Launched Krestin®, an anti-cancer drug	1977 Showa 52		-
	-	1979 Showa 54		・Launched Neuer®, a peptic ulcer agent ・Launched Karoyan ®S, a hair-loss prevention and vitiligo agent
	・Launched Cefmetazon®, a cephamycin-type antibiotic	1980 Showa 55		・Representative New York office establishment
	-	1981 Showa 56		・Started operation of Akita plant
	-			・Launched Panaldine®, an anti-blood-platelet agent
	・Launched Captoril®, the world's first renin-angiotensin-type hypertensive drug	1983 Showa 58		・Provided technology on Trivid®, a broad-spectrum antibacterial agent, to Johnson & Johnson of the USA and Hoechst of Germany
	・Launched Zantac®, an H2-receptor anatagonist/gastrointestinal ulcer drug	1984 Showa 59		-
	・Established Sankyo USA Corporation (New York City, USA) ・Established Sankyo Europa GmbH (Dusseldorf, Germany)	1985 Showa 60		・Launched Feron®, a β-interferon preparation
	-			・Launched Tarivid® , a broad-spectrum oral antibacterial agent, in Japan and West Germany
	・Launched Loxonin®, an oral non-steroid analgesic and anti-inflammatory drug	1986 Showa 61		・Formulated the corporate slogan Enriching the Quality of Life
	・Established Onahama plant	1987 Showa 62		・Launched Omnipark®, a non-ionic contrast media
	-			・Launched Senlock Pellet®, a gastrointestinal agent (OTC medicine)
	・Launched Regain®, a mini-bottled vitamin tonic	1988 Showa 63		-
	・World launch of Mevalotin®, an epoch-making HMG-CoA reductase inhibitor (hyperlipidemic drug) ・Launched Banan®, an oral cephalosporin antibiotic	1989 Start of Heisei		・Established Sanofi Daiichi Co., Ltd (Japan)
	・Luitpold Werk GmbH becomes 100% owned subsidiary	1990 Heisei 2		・ Launched Karoyan Apogeeca®, a hair-loss prevention and antivitiligo agent ・ Established Korea Daiichi Pharmaceutical Co., Ltd. ・ Estabished Tokyo Research and Development Center
	-	1991 Heisei 3		・Launched ofloxacin in the U.S(Floxin).(Japanese name:“Tarivid”)
	・Awarded the Ohkochi Memorial Grand Production Prize for the hyperlipidemic drug Pravastain (manufactured as Mevalotin®)	1992 Heisei 4		Launched Patecs® analgesic (OTC drug)
	-	1993 Heisei 5		・Launched Cravit®, a broad-spectrum oral antibacterial agent
	-			・Established Daiichi Pharmaceutical UK Ltd. (UK)
	・Completed new Head Office in Nihombashi, Tokyo	1994 Heisei 6		・Launched Kuromaru Drink®, an aldioxa for stomach discomfort
	・Launched Acecol®, an Ace inhibitor of biliary and renal-excretion type			・Launched NF Karoyan Apogeeca®, a hair-loss prevention and antivitiligo agent
	・Completed Central Logistics Center	1996 Heisei 8		・Launched Senlock®, herb minute grain
	・Established Sankyo Pharma Inc. (New Jersey, USA) ・Established Sankyo Parke Davis (New Jersey, USA)			-
	・Luitpold Pharma GmbH becomes Sankyo Pharma GmbH	1997 Heisei 9		-
	・Onahama plant and Odawara plant receive ISO14001 certification, first time for a Japanese pharmaceutical company ・Establishment of Sankyo Pharma Research Institute in California, USA, for development of new medicines	1998 Heisei 10		・Establishment of Daiichi Pharmaceutical (Beijing) Co. Ltd. ・Launched Coversyl®, an Ace inhibitor
	・Centenary of founding	1999 Heisei 11		-
	・Formulated corporate slogan, CARE & CURE for everyone	2001 Heisei 13		-
	・Launched Fastic®, a drug for lowering blood sugar	2002 Heisei 14		-
	・Launched Olmesartan, a strategic global product (manufactured as Benicar® in the USA and Olmetec® in Germany)			-
	・Agrochemicals Division spun off as Sankyo Agro Co., Ltd. ・Special Merchandise Division spun off as Sankyo Lifetech Co., Ltd.	2003 Heisei 15		・Launched Cystina C®, (OTC drug), a vitamin C product
	・Launched Calblock®, an antihypertensive agent ・Launched Livalo®, a cholesterol-lowering agent			-
	・Launched global strategic product Olmesartan in Japan (manufactured as Olmetec®)	2004 Heisei 16		・Started independent sale of Mobic®, a nonsteroidal anti-inflammatory agent, in Japan
	-			・Launched Senlock®, (OTC drug)
	-			・Launched Kyukyu Patecs ID Spray® (OTC drug)
	-			・Launched Rejuage Q10 Cream® (cosmetic)
	・Launched Black Regain® refreshing beverage	2005 Heisei 17		-

Year	History of DAIICHI SANKYO COMPANY, LIMITED
2005 Heisei 17		Establishment of DAIICHI SANKYO COMPANY, LIMITED (Sankyo Co., Ltd. and Daiichi Pharmaceutical Co., Ltd. a joint-holding company
2006 Heisei 18		・Started operation of DAIICHI SANKYO HEALTHCARE CO., LTD. (an amalgamtion of the health care operations of Sankyo co., Ltd. and Daiichi Pharmaceutical Co., Ltd.) ・Started operations of DAIICHI SANKYO Inc. (an amalgamation of the operations of Sankyo Co., Ltd. and Daiichi Pharmaceutical Co., Ltd.'s US subsidiary corporation) ・Started operations of Daiichi Sankyo Europe GmbH, the new European organization
		・Launched Urief®, a drug for the amelioration of urinary damage (Daiichi Pharmaceuticals)
2007 Heisei 19		April 1, 2007 Started operations as the newly formed DAIICHI SANKYO Group